Page 2 - Director Vicky News Today

Quest Diagnostics (NYSE:DGX – Get Free Report) released its earnings results on Tuesday. The medical research company reported $2.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.86 by $0.18, Briefing.com reports. The firm had revenue of $2.37 billion during the quarter, compared to the consensus estimate of $2.29 billion. Quest Diagnostics […]

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price boosted by investment analysts at Citigroup from $135.00 to $145.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the medical research company’s stock. Citigroup’s target price suggests a potential upside of 5.27% from the company’s previous […]

Quest Diagnostics (NYSE:DGX – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $8.72-$8.97 for the period, compared to the consensus earnings per share estimate of $8.75. The company issued revenue guidance of $9.40-$9.48 billion, compared to the consensus revenue estimate of […]

Quest Diagnostics (NYSE:DGX – Get Free Report) announced its quarterly earnings data on Tuesday. The medical research company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.86 by $0.18, Briefing.com reports. Quest Diagnostics had a net margin of 9.23% and a return on equity of 15.79%. The firm had revenue […]

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price hoisted by research analysts at Citigroup from $135.00 to $145.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the medical research company’s stock. Citigroup’s price target suggests a potential upside of 5.27% from the company’s current […]

CNB Bank trimmed its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 4.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,449 shares of the medical research company’s stock after selling 393 shares during the period. CNB Bank’s holdings in […]

StockNews.com lowered shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a report published on Wednesday. A number of other research firms have also commented on DGX. Jefferies Financial Group upgraded shares of Quest Diagnostics from a hold rating to a buy rating and lifted their price […]

Knights of Columbus Asset Advisors LLC increased its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 2.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 46,799 shares of the medical research company’s stock after purchasing an additional 1,038 […]

Olstein Capital Management L.P. lowered its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 14.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 58,000 shares of the medical research company’s stock after selling 10,000 shares during the […]

Truist Financial reissued their hold rating on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report published on Wednesday, Benzinga reports. They currently have a $145.00 price objective on the medical research company’s stock. A number of other research analysts also recently weighed in on the company. UBS Group raised their price objective […]